Research Projects

IDP4SCLC Drug optimization of new therapeutic targets IDP (ASCL1) for the treatment of small cell lung cancer

Dr. Fernando Lecanda Cordero Curriculum
Researcher | Principal Investigator Research Group Biomarkers and New Therapeutic Targets in Lung Cancer
Research Division
Cancer Division
Research program
Solid Tumors
Research group
Biomarkers and New Targets in Lung Cancer
Disease
Microcytic lung carcinoma

Project information

  • Reference: RTC-2017-6585-1
  • Duration: 2 years
  • Start date: January 1, 2018
  • End date: December 31, 2020
  • Funder: FEDER/Ministerio de Ciencia, Innovación y Universidades – Agencia Estatal de Investigación
  • Grant: 168,654.40€
  • Nature of project: National

Need more information?

If you are interested in learning more about our research, please contact us.